Pre-order Enquiry
Request Free Sample
Global Macular Degeneration (AMD) and Other Retinal Diseases Market Research Report 2022
SKU ID : QYR-21415709 | Publishing Date : 03-Aug-2022 | No. of pages : 90
Detailed TOC of Global Macular Degeneration (AMD) and Other Retinal Diseases Market Research Report 2022
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Macular Degeneration
1.2.3 Diabetic Macular Edema
1.2.4 Diabetic Retinopathy(DR)
1.2.5 Retinal Vein Occlusion
1.2.6 Wet Age-Related Macular Degeneration (wAMD)
1.2.7 Dry Age-Related Macular Degeneration (dAMD)
1.2.8 Other
1.3 Market by Application
1.3.1 Global Macular Degeneration (AMD) and Other Retinal Diseases Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Macular Degeneration (AMD) and Other Retinal Diseases Market Perspective (2017-2028)
2.2 Macular Degeneration (AMD) and Other Retinal Diseases Growth Trends by Region
2.2.1 Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Macular Degeneration (AMD) and Other Retinal Diseases Historic Market Size by Region (2017-2022)
2.2.3 Macular Degeneration (AMD) and Other Retinal Diseases Forecasted Market Size by Region (2023-2028)
2.3 Macular Degeneration (AMD) and Other Retinal Diseases Market Dynamics
2.3.1 Macular Degeneration (AMD) and Other Retinal Diseases Industry Trends
2.3.2 Macular Degeneration (AMD) and Other Retinal Diseases Market Drivers
2.3.3 Macular Degeneration (AMD) and Other Retinal Diseases Market Challenges
2.3.4 Macular Degeneration (AMD) and Other Retinal Diseases Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Macular Degeneration (AMD) and Other Retinal Diseases Players by Revenue
3.1.1 Global Top Macular Degeneration (AMD) and Other Retinal Diseases Players by Revenue (2017-2022)
3.1.2 Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue Market Share by Players (2017-2022)
3.2 Global Macular Degeneration (AMD) and Other Retinal Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Macular Degeneration (AMD) and Other Retinal Diseases Revenue
3.4 Global Macular Degeneration (AMD) and Other Retinal Diseases Market Concentration Ratio
3.4.1 Global Macular Degeneration (AMD) and Other Retinal Diseases Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Macular Degeneration (AMD) and Other Retinal Diseases Revenue in 2021
3.5 Macular Degeneration (AMD) and Other Retinal Diseases Key Players Head office and Area Served
3.6 Key Players Macular Degeneration (AMD) and Other Retinal Diseases Product Solution and Service
3.7 Date of Enter into Macular Degeneration (AMD) and Other Retinal Diseases Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Macular Degeneration (AMD) and Other Retinal Diseases Breakdown Data by Type
4.1 Global Macular Degeneration (AMD) and Other Retinal Diseases Historic Market Size by Type (2017-2022)
4.2 Global Macular Degeneration (AMD) and Other Retinal Diseases Forecasted Market Size by Type (2023-2028)
5 Macular Degeneration (AMD) and Other Retinal Diseases Breakdown Data by Application
5.1 Global Macular Degeneration (AMD) and Other Retinal Diseases Historic Market Size by Application (2017-2022)
5.2 Global Macular Degeneration (AMD) and Other Retinal Diseases Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Macular Degeneration (AMD) and Other Retinal Diseases Market Size (2017-2028)
6.2 North America Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Country (2017-2022)
6.3 North America Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Macular Degeneration (AMD) and Other Retinal Diseases Market Size (2017-2028)
7.2 Europe Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Country (2017-2022)
7.3 Europe Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Macular Degeneration (AMD) and Other Retinal Diseases Market Size (2017-2028)
8.2 Asia-Pacific Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Country (2017-2022)
8.3 Asia-Pacific Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Macular Degeneration (AMD) and Other Retinal Diseases Market Size (2017-2028)
9.2 Latin America Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Country (2017-2022)
9.3 Latin America Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Macular Degeneration (AMD) and Other Retinal Diseases Market Size (2017-2028)
10.2 Middle East & Africa Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Country (2017-2022)
10.3 Middle East & Africa Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Regeneron Pharmaceuticals
11.1.1 Regeneron Pharmaceuticals Company Detail
11.1.2 Regeneron Pharmaceuticals Business Overview
11.1.3 Regeneron Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Introduction
11.1.4 Regeneron Pharmaceuticals Revenue in Macular Degeneration (AMD) and Other Retinal Diseases Business (2017-2022)
11.1.5 Regeneron Pharmaceuticals Recent Development
11.2 Bayer HealthCare
11.2.1 Bayer HealthCare Company Detail
11.2.2 Bayer HealthCare Business Overview
11.2.3 Bayer HealthCare Macular Degeneration (AMD) and Other Retinal Diseases Introduction
11.2.4 Bayer HealthCare Revenue in Macular Degeneration (AMD) and Other Retinal Diseases Business (2017-2022)
11.2.5 Bayer HealthCare Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Macular Degeneration (AMD) and Other Retinal Diseases Introduction
11.3.4 Novartis Revenue in Macular Degeneration (AMD) and Other Retinal Diseases Business (2017-2022)
11.3.5 Novartis Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Macular Degeneration (AMD) and Other Retinal Diseases Introduction
11.4.4 Roche Revenue in Macular Degeneration (AMD) and Other Retinal Diseases Business (2017-2022)
11.4.5 Roche Recent Development
11.5 Kanghong Pharma
11.5.1 Kanghong Pharma Company Detail
11.5.2 Kanghong Pharma Business Overview
11.5.3 Kanghong Pharma Macular Degeneration (AMD) and Other Retinal Diseases Introduction
11.5.4 Kanghong Pharma Revenue in Macular Degeneration (AMD) and Other Retinal Diseases Business (2017-2022)
11.5.5 Kanghong Pharma Recent Development
11.6 Merck
11.6.1 Merck Company Detail
11.6.2 Merck Business Overview
11.6.3 Merck Macular Degeneration (AMD) and Other Retinal Diseases Introduction
11.6.4 Merck Revenue in Macular Degeneration (AMD) and Other Retinal Diseases Business (2017-2022)
11.6.5 Merck Recent Development
11.7 Allergan
11.7.1 Allergan Company Detail
11.7.2 Allergan Business Overview
11.7.3 Allergan Macular Degeneration (AMD) and Other Retinal Diseases Introduction
11.7.4 Allergan Revenue in Macular Degeneration (AMD) and Other Retinal Diseases Business (2017-2022)
11.7.5 Allergan Recent Development
11.8 Santen Pharmaceutical
11.8.1 Santen Pharmaceutical Company Detail
11.8.2 Santen Pharmaceutical Business Overview
11.8.3 Santen Pharmaceutical Macular Degeneration (AMD) and Other Retinal Diseases Introduction
11.8.4 Santen Pharmaceutical Revenue in Macular Degeneration (AMD) and Other Retinal Diseases Business (2017-2022)
11.8.5 Santen Pharmaceutical Recent Development
11.9 GlaxoSmithKline Pharmaceuticals
11.9.1 GlaxoSmithKline Pharmaceuticals Company Detail
11.9.2 GlaxoSmithKline Pharmaceuticals Business Overview
11.9.3 GlaxoSmithKline Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Introduction
11.9.4 GlaxoSmithKline Pharmaceuticals Revenue in Macular Degeneration (AMD) and Other Retinal Diseases Business (2017-2022)
11.9.5 GlaxoSmithKline Pharmaceuticals Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Detail
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Macular Degeneration (AMD) and Other Retinal Diseases Introduction
11.10.4 Pfizer Revenue in Macular Degeneration (AMD) and Other Retinal Diseases Business (2017-2022)
11.10.5 Pfizer Recent Development
11.11 Acucela
11.11.1 Acucela Company Detail
11.11.2 Acucela Business Overview
11.11.3 Acucela Macular Degeneration (AMD) and Other Retinal Diseases Introduction
11.11.4 Acucela Revenue in Macular Degeneration (AMD) and Other Retinal Diseases Business (2017-2022)
11.11.5 Acucela Recent Development
11.12 Valent Pharmaceuticals
11.12.1 Valent Pharmaceuticals Company Detail
11.12.2 Valent Pharmaceuticals Business Overview
11.12.3 Valent Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Introduction
11.12.4 Valent Pharmaceuticals Revenue in Macular Degeneration (AMD) and Other Retinal Diseases Business (2017-2022)
11.12.5 Valent Pharmaceuticals Recent Development
11.13 IVERIC
11.13.1 IVERIC Company Detail
11.13.2 IVERIC Business Overview
11.13.3 IVERIC Macular Degeneration (AMD) and Other Retinal Diseases Introduction
11.13.4 IVERIC Revenue in Macular Degeneration (AMD) and Other Retinal Diseases Business (2017-2022)
11.13.5 IVERIC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Macular Degeneration (AMD) and Other Retinal Diseases Market Research Report 2022
List of TablesTable 1. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Macular Degeneration
Table 3. Key Players of Diabetic Macular Edema
Table 4. Key Players of Diabetic Retinopathy(DR)
Table 5. Key Players of Retinal Vein Occlusion
Table 6. Key Players of Wet Age-Related Macular Degeneration (wAMD)
Table 7. Key Players of Dry Age-Related Macular Degeneration (dAMD)
Table 8. Key Players of Other
Table 9. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 10. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 11. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Region (2017-2022) & (US$ Million)
Table 12. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Share by Region (2017-2022)
Table 13. Global Macular Degeneration (AMD) and Other Retinal Diseases Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 14. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Share by Region (2023-2028)
Table 15. Macular Degeneration (AMD) and Other Retinal Diseases Market Trends
Table 16. Macular Degeneration (AMD) and Other Retinal Diseases Market Drivers
Table 17. Macular Degeneration (AMD) and Other Retinal Diseases Market Challenges
Table 18. Macular Degeneration (AMD) and Other Retinal Diseases Market Restraints
Table 19. Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue by Players (2017-2022) & (US$ Million)
Table 20. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Share by Players (2017-2022)
Table 21. Global Top Macular Degeneration (AMD) and Other Retinal Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Macular Degeneration (AMD) and Other Retinal Diseases as of 2021)
Table 22. Ranking of Global Top Macular Degeneration (AMD) and Other Retinal Diseases Companies by Revenue (US$ Million) in 2021
Table 23. Global 5 Largest Players Market Share by Macular Degeneration (AMD) and Other Retinal Diseases Revenue (CR5 and HHI) & (2017-2022)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Macular Degeneration (AMD) and Other Retinal Diseases Product Solution and Service
Table 26. Date of Enter into Macular Degeneration (AMD) and Other Retinal Diseases Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Type (2017-2022) & (US$ Million)
Table 29. Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue Market Share by Type (2017-2022)
Table 30. Global Macular Degeneration (AMD) and Other Retinal Diseases Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 31. Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue Market Share by Type (2023-2028)
Table 32. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Application (2017-2022) & (US$ Million)
Table 33. Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue Market Share by Application (2017-2022)
Table 34. Global Macular Degeneration (AMD) and Other Retinal Diseases Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 35. Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue Market Share by Application (2023-2028)
Table 36. North America Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Country (2017-2022) & (US$ Million)
Table 39. Europe Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Country (2023-2028) & (US$ Million)
Table 40. Asia-Pacific Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Region (2017-2022) & (US$ Million)
Table 41. Asia-Pacific Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Region (2023-2028) & (US$ Million)
Table 42. Latin America Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Country (2017-2022) & (US$ Million)
Table 43. Latin America Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Country (2023-2028) & (US$ Million)
Table 44. Middle East & Africa Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Country (2017-2022) & (US$ Million)
Table 45. Middle East & Africa Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Country (2023-2028) & (US$ Million)
Table 46. Regeneron Pharmaceuticals Company Detail
Table 47. Regeneron Pharmaceuticals Business Overview
Table 48. Regeneron Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Product
Table 49. Regeneron Pharmaceuticals Revenue in Macular Degeneration (AMD) and Other Retinal Diseases Business (2017-2022) & (US$ Million)
Table 50. Regeneron Pharmaceuticals Recent Development
Table 51. Bayer HealthCare Company Detail
Table 52. Bayer HealthCare Business Overview
Table 53. Bayer HealthCare Macular Degeneration (AMD) and Other Retinal Diseases Product
Table 54. Bayer HealthCare Revenue in Macular Degeneration (AMD) and Other Retinal Diseases Business (2017-2022) & (US$ Million)
Table 55. Bayer HealthCare Recent Development
Table 56. Novartis Company Detail
Table 57. Novartis Business Overview
Table 58. Novartis Macular Degeneration (AMD) and Other Retinal Diseases Product
Table 59. Novartis Revenue in Macular Degeneration (AMD) and Other Retinal Diseases Business (2017-2022) & (US$ Million)
Table 60. Novartis Recent Development
Table 61. Roche Company Detail
Table 62. Roche Business Overview
Table 63. Roche Macular Degeneration (AMD) and Other Retinal Diseases Product
Table 64. Roche Revenue in Macular Degeneration (AMD) and Other Retinal Diseases Business (2017-2022) & (US$ Million)
Table 65. Roche Recent Development
Table 66. Kanghong Pharma Company Detail
Table 67. Kanghong Pharma Business Overview
Table 68. Kanghong Pharma Macular Degeneration (AMD) and Other Retinal Diseases Product
Table 69. Kanghong Pharma Revenue in Macular Degeneration (AMD) and Other Retinal Diseases Business (2017-2022) & (US$ Million)
Table 70. Kanghong Pharma Recent Development
Table 71. Merck Company Detail
Table 72. Merck Business Overview
Table 73. Merck Macular Degeneration (AMD) and Other Retinal Diseases Product
Table 74. Merck Revenue in Macular Degeneration (AMD) and Other Retinal Diseases Business (2017-2022) & (US$ Million)
Table 75. Merck Recent Development
Table 76. Allergan Company Detail
Table 77. Allergan Business Overview
Table 78. Allergan Macular Degeneration (AMD) and Other Retinal Diseases Product
Table 79. Allergan Revenue in Macular Degeneration (AMD) and Other Retinal Diseases Business (2017-2022) & (US$ Million)
Table 80. Allergan Recent Development
Table 81. Santen Pharmaceutical Company Detail
Table 82. Santen Pharmaceutical Business Overview
Table 83. Santen Pharmaceutical Macular Degeneration (AMD) and Other Retinal Diseases Product
Table 84. Santen Pharmaceutical Revenue in Macular Degeneration (AMD) and Other Retinal Diseases Business (2017-2022) & (US$ Million)
Table 85. Santen Pharmaceutical Recent Development
Table 86. GlaxoSmithKline Pharmaceuticals Company Detail
Table 87. GlaxoSmithKline Pharmaceuticals Business Overview
Table 88. GlaxoSmithKline Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Product
Table 89. GlaxoSmithKline Pharmaceuticals Revenue in Macular Degeneration (AMD) and Other Retinal Diseases Business (2017-2022) & (US$ Million)
Table 90. GlaxoSmithKline Pharmaceuticals Recent Development
Table 91. Pfizer Company Detail
Table 92. Pfizer Business Overview
Table 93. Pfizer Macular Degeneration (AMD) and Other Retinal Diseases Product
Table 94. Pfizer Revenue in Macular Degeneration (AMD) and Other Retinal Diseases Business (2017-2022) & (US$ Million)
Table 95. Pfizer Recent Development
Table 96. Acucela Company Detail
Table 97. Acucela Business Overview
Table 98. Acucela Macular Degeneration (AMD) and Other Retinal DiseasesProduct
Table 99. Acucela Revenue in Macular Degeneration (AMD) and Other Retinal Diseases Business (2017-2022) & (US$ Million)
Table 100. Acucela Recent Development
Table 101. Valent Pharmaceuticals Company Detail
Table 102. Valent Pharmaceuticals Business Overview
Table 103. Valent Pharmaceuticals Macular Degeneration (AMD) and Other Retinal DiseasesProduct
Table 104. Valent Pharmaceuticals Revenue in Macular Degeneration (AMD) and Other Retinal Diseases Business (2017-2022) & (US$ Million)
Table 105. Valent Pharmaceuticals Recent Development
Table 106. IVERIC Company Detail
Table 107. IVERIC Business Overview
Table 108. IVERIC Macular Degeneration (AMD) and Other Retinal DiseasesProduct
Table 109. IVERIC Revenue in Macular Degeneration (AMD) and Other Retinal Diseases Business (2017-2022) & (US$ Million)
Table 110. IVERIC Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Share by Type: 2021 VS 2028
Figure 2. Macular Degeneration Features
Figure 3. Diabetic Macular Edema Features
Figure 4. Diabetic Retinopathy(DR) Features
Figure 5. Retinal Vein Occlusion Features
Figure 6. Wet Age-Related Macular Degeneration (wAMD) Features
Figure 7. Dry Age-Related Macular Degeneration (dAMD) Features
Figure 8. Other Features
Figure 9. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Share by Application in 2021 & 2028
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Other Case Studies
Figure 13. Macular Degeneration (AMD) and Other Retinal Diseases Report Years Considered
Figure 14. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 15. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Share by Region: 2021 VS 2028
Figure 17. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Share by Players in 2021
Figure 18. Global Top Macular Degeneration (AMD) and Other Retinal Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Macular Degeneration (AMD) and Other Retinal Diseases as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by Macular Degeneration (AMD) and Other Retinal Diseases Revenue in 2021
Figure 20. North America Macular Degeneration (AMD) and Other Retinal Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. North America Macular Degeneration (AMD) and Other Retinal Diseases Market Share by Country (2017-2028)
Figure 22. United States Macular Degeneration (AMD) and Other Retinal Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Macular Degeneration (AMD) and Other Retinal Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Macular Degeneration (AMD) and Other Retinal Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Macular Degeneration (AMD) and Other Retinal Diseases Market Share by Country (2017-2028)
Figure 26. Germany Macular Degeneration (AMD) and Other Retinal Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Macular Degeneration (AMD) and Other Retinal Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Macular Degeneration (AMD) and Other Retinal Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Macular Degeneration (AMD) and Other Retinal Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Macular Degeneration (AMD) and Other Retinal Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Macular Degeneration (AMD) and Other Retinal Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Macular Degeneration (AMD) and Other Retinal Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Macular Degeneration (AMD) and Other Retinal Diseases Market Share by Region (2017-2028)
Figure 34. China Macular Degeneration (AMD) and Other Retinal Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Japan Macular Degeneration (AMD) and Other Retinal Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. South Korea Macular Degeneration (AMD) and Other Retinal Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Southeast Asia Macular Degeneration (AMD) and Other Retinal Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. India Macular Degeneration (AMD) and Other Retinal Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Australia Macular Degeneration (AMD) and Other Retinal Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Latin America Macular Degeneration (AMD) and Other Retinal Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Latin America Macular Degeneration (AMD) and Other Retinal Diseases Market Share by Country (2017-2028)
Figure 42. Mexico Macular Degeneration (AMD) and Other Retinal Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Brazil Macular Degeneration (AMD) and Other Retinal Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Middle East & Africa Macular Degeneration (AMD) and Other Retinal Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Middle East & Africa Macular Degeneration (AMD) and Other Retinal Diseases Market Share by Country (2017-2028)
Figure 46. Turkey Macular Degeneration (AMD) and Other Retinal Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Saudi Arabia Macular Degeneration (AMD) and Other Retinal Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Regeneron Pharmaceuticals Revenue Growth Rate in Macular Degeneration (AMD) and Other Retinal Diseases Business (2017-2022)
Figure 49. Bayer HealthCare Revenue Growth Rate in Macular Degeneration (AMD) and Other Retinal Diseases Business (2017-2022)
Figure 50. Novartis Revenue Growth Rate in Macular Degeneration (AMD) and Other Retinal Diseases Business (2017-2022)
Figure 51. Roche Revenue Growth Rate in Macular Degeneration (AMD) and Other Retinal Diseases Business (2017-2022)
Figure 52. Kanghong Pharma Revenue Growth Rate in Macular Degeneration (AMD) and Other Retinal Diseases Business (2017-2022)
Figure 53. Merck Revenue Growth Rate in Macular Degeneration (AMD) and Other Retinal Diseases Business (2017-2022)
Figure 54. Allergan Revenue Growth Rate in Macular Degeneration (AMD) and Other Retinal Diseases Business (2017-2022)
Figure 55. Santen Pharmaceutical Revenue Growth Rate in Macular Degeneration (AMD) and Other Retinal Diseases Business (2017-2022)
Figure 56. GlaxoSmithKline Pharmaceuticals Revenue Growth Rate in Macular Degeneration (AMD) and Other Retinal Diseases Business (2017-2022)
Figure 57. Pfizer Revenue Growth Rate in Macular Degeneration (AMD) and Other Retinal Diseases Business (2017-2022)
Figure 58. Acucela Revenue Growth Rate in Macular Degeneration (AMD) and Other Retinal Diseases Business (2017-2022)
Figure 59. Valent Pharmaceuticals Revenue Growth Rate in Macular Degeneration (AMD) and Other Retinal Diseases Business (2017-2022)
Figure 60. IVERIC Revenue Growth Rate in Macular Degeneration (AMD) and Other Retinal Diseases Business (2017-2022)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Keyplayers in Global Macular Degeneration (AMD) and Other Retinal Diseases Market Research Report 2022
Regeneron PharmaceuticalsBayer HealthCare
Novartis
Roche
Kanghong Pharma
Merck
Allergan
Santen Pharmaceutical
GlaxoSmithKline Pharmaceuticals
Pfizer
Acucela
Valent Pharmaceuticals
IVERIC
Request Sample
Request Discount
